newsfilter
← Latest News
GlobeNewswire·

Cyclerion Therapeutics Reports Third Quarter 2021 Financial Results and Corporate Update

First patients enrolled in study in Cognitive Impairment Associated with Schizophrenia (CIAS) Patient screening underway in study in Alzheimer's disease with vascular pathology (ADv) Enrollment ongoing in study in Mitochondrial Encephalomyopathy, L